{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:48:19Z","timestamp":1787676499365,"version":"build-2784847793"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":1346,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Swedish Cancer foundation, Region Sk\u00e5ne, and the Knut and Alice Wallenberg foundation"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.exphem.2018.06.288","type":"journal-article","created":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T14:15:18Z","timestamp":1530800118000},"page":"27-31.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Bone marrow eosinophils in plasma cell disorders"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9289-8617","authenticated-orcid":false,"given":"Stina","family":"Wichert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5sa","family":"Pettersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2952-1155","authenticated-orcid":false,"given":"Thomas","family":"Hellmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5sa","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7715-4548","authenticated-orcid":false,"given":"Markus","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2018.06.288_bib0001","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/ni.1981","article-title":"Eosinophils are required for the maintenance of plasma cells in the bone marrow","volume":"12","author":"Chu","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.exphem.2018.06.288_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109018","article-title":"Eosinophils and megakaryocytes support the early growth of murine MOPC315 myeloma cells in their bone marrow niches","volume":"9","author":"Wong","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2018.06.288_bib0003","doi-asserted-by":"crossref","first-page":"e70554","DOI":"10.1371\/journal.pone.0070554","article-title":"Induction of malignant plasma cell proliferation by eosinophils","volume":"8","author":"Wong","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2018.06.288_bib0004","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/imm.12658","article-title":"Effective antigen presentation to helper T cells by human eosinophils","volume":"149","author":"Farhan","year":"2016","journal-title":"Immunology"},{"key":"10.1016\/j.exphem.2018.06.288_bib0005","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.3389\/fimmu.2017.01781","article-title":"Granulocytes: new members of the antigen-presenting cell family","volume":"8","author":"Lin","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.exphem.2018.06.288_bib0006","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3389\/fimmu.2014.00570","article-title":"Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity","volume":"5","author":"Davoine","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.exphem.2018.06.288_bib0007","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s00262-012-1288-3","article-title":"Involvement of eosinophils in the anti-tumor response","volume":"61","author":"Gatault","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.exphem.2018.06.288_bib0008","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/ni.3159","article-title":"Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8(+) T cells","volume":"16","author":"Carretero","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.exphem.2018.06.288_bib0009","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.4049\/jimmunol.1601005","article-title":"Regulatory eosinophils suppress T cells partly through galectin-10","volume":"198","author":"Lingblom","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2018.06.288_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/2326-6066.CIR-13-0196","article-title":"Eosinophils and cancer","volume":"2","author":"Davis","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.exphem.2018.06.288_bib0011","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1182\/blood.V95.4.1207.004k34_1207_1213","article-title":"Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors","volume":"95","author":"von Wasielewski R","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.06.288_bib0012","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nri3158","article-title":"Standardizing immunophenotyping for the Human Immunology Project","volume":"12","author":"Maecker","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.exphem.2018.06.288_bib0013","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1017\/cts.2016.20","article-title":"Glucocorticoid receptor expression on circulating leukocytes differs between healthy male and female adults","volume":"1","author":"Lu","year":"2017","journal-title":"J Clin Transl Sci"},{"key":"10.1016\/j.exphem.2018.06.288_bib0014","doi-asserted-by":"crossref","first-page":"C1324","DOI":"10.1152\/ajpcell.00363.2001","article-title":"Expression of glucocorticoid receptor alpha- and beta-isoforms in human cells and tissues","volume":"283","author":"Pujols","year":"2002","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.exphem.2018.06.288_bib0015","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.4049\/jimmunol.156.11.4422","article-title":"Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes","volume":"156","author":"Meagher","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2018.06.288_bib0016","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1046\/j.1365-2141.2003.04700.x","article-title":"Differential effect of dexamethasone on cell death and STAT5 activation during in vitro eosinopoiesis","volume":"123","author":"Debierre-Grockiego","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2018.06.288_bib0017","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1084\/jem.194.1.45","article-title":"A coordinated change in chemokine responsiveness guides plasma cell movements","volume":"194","author":"Hargreaves","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2018.06.288_bib0018","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jim.2012.10.006","article-title":"Purification of functional eosinophils\nfrom human bone marrow","volume":"387","author":"Wong","year":"2013","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.exphem.2018.06.288_bib0019","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nri3132","article-title":"The bone marrow at the crossroads of blood and immunity","volume":"12","author":"Mercier","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.exphem.2018.06.288_bib0020","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/cea.12292","article-title":"Activation states of blood eosinophils in asthma","volume":"44","author":"Johansson","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.exphem.2018.06.288_bib0021","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/imcb.1003","article-title":"Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells","volume":"96","author":"Sasidharan Nair","year":"2018","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.exphem.2018.06.288_bib0022","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/35105024","article-title":"T-cell regulation by CD28 and CTLA-4","volume":"1","author":"Alegre","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.exphem.2018.06.288_bib0023","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/346574a0","article-title":"Quantitation of antigen-presenting cell MHC class II\/peptide complexes necessary for T-cell stimulation","volume":"346","author":"Harding","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2018.06.288_bib0024","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13045-016-0345-3","article-title":"T cells in multiple myeloma display features of exhaustion and senescence at the tumor site","volume":"9","author":"Zelle-Rieser","year":"2016","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.exphem.2018.06.288_bib0025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.immuni.2007.05.016","article-title":"Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses","volume":"27","author":"Butte","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.exphem.2018.06.288_bib0026","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.exphem.2018.06.288_bib0027","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ccell.2016.06.001","article-title":"Origin and role of a subset of tumor-associated neutrophils with antigen-presenting cell features in early-stage human lung cancer","volume":"30","author":"Singhal","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2018.06.288_bib0028","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3324\/haematol.2016.150656","article-title":"The emerging role of immune checkpoint inhibition in malignant lymphoma","volume":"102","author":"Hude","year":"2017","journal-title":"Haematologica"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X18306210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X18306210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:33:32Z","timestamp":1759566812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X18306210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":28,"alternative-id":["S0301472X18306210"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2018.06.288","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone marrow eosinophils in plasma cell disorders","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2018.06.288","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc. on behalf of ISEH -- Society for Hematology and Stem Cells.","name":"copyright","label":"Copyright"}]}}